Tumor Burden Reduction

Favorable Outcomes With Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Higher Risk Myelodysplastic Syndrome Patients

Stella Richards 0Comment

DOI: 10.1016/j.clml.2019.03.016 Abstract A groundbreaking study has recently brought forth optimistic findings for patients with…